Sabrina Noettger

Albert Einstein Allee 11
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Replication-competent SIVcpz CRISPR screen identifies barriers to successful cross-species transmission.

Replication-competent SIVcpz CRISPR screen identifies barriers to successful cross-species transmission.

Journal: Journal of virology
Published: May 07, 2026

Human Coronavirus 229E Uses ORF4/4a to Antagonize the Host Restriction Factor SERINC5.

Human Coronavirus 229E Uses ORF4/4a to Antagonize the Host Restriction Factor SERINC5.

Journal: MedComm
Published: August 13, 2025

Host ZAP activity correlates with the levels of CpG suppression in primate lentiviruses.

Host ZAP activity correlates with the levels of CpG suppression in primate lentiviruses.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 03, 2025

Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection.

Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection.

Journal: Journal of virology
Published: March 28, 2025

Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization.

Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization.

Journal: iScience
Published: May 30, 2023

Determinants of species-specific utilization of ACE2 by human and animal coronaviruses.

Determinants of species-specific utilization of ACE2 by human and animal coronaviruses.

Journal: Communications biology
Published: April 27, 2023

SARS-CoV-2 inhibition and specific targeting of infected cells by VSV particles carrying the ACE2 receptor.

SARS-CoV-2 inhibition and specific targeting of infected cells by VSV particles carrying the ACE2 receptor.

Journal: Signal transduction and targeted therapy
Published: February 06, 2023

Endogenous IFITMs boost SARS-coronavirus 1 and 2 replication whereas overexpression inhibits infection by relocalizing ACE2.

Endogenous IFITMs boost SARS-coronavirus 1 and 2 replication whereas overexpression inhibits infection by relocalizing ACE2.

Journal: iScience
Published: October 19, 2022

Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1.

Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1.

Journal: Life science alliance
Published: September 29, 2022

Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes.

Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes.

Journal: Signal transduction and targeted therapy
Published: May 24, 2022

Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.

Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.

Journal: Cell host & microbe
Published: April 25, 2022

The enzyme subunit SubA of Shiga toxin-producing E. coli strains demonstrates comparable intracellular transport and cytotoxic activity as the holotoxin SubAB in HeLa and HCT116 cells in vitro.

The enzyme subunit SubA of Shiga toxin-producing E. coli strains demonstrates comparable intracellular transport and cytotoxic activity as the holotoxin SubAB in HeLa and HCT116 cells in vitro.

Journal: Archives of toxicology
Published: September 11, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026